Narrative review / 2011
A review argues that the minimum desirable serum 25-hydroxyvitamin D level should exceed 75 nmol/L rather than the IOM recommendation of 50 nmol/L.
This article examines the Institute of Medicine (IOM) recommendation to maintain serum 25-hydroxyvitamin D (25(OH)D) at or above 50 nmol/L. The author argues that 25(OH)D should preferably exceed 75 nmol/L (30 ng/mL) based on re-evaluation of bone density and osteomalacia data, evolutionary biology, clinical trials, and epidemiological links to fewer falls, better tooth attachment, less colorectal cancer, and improved depression. The author attributes reported risks of prostate cancer, pancreatic cancer, or mortality at higher latitudes to dynamic seasonal fluctuations in 25(OH)D.
- Study type
- Narrative review / commentary
- Who was studied
- Human populations reviewed in relation to vitamin D recommendations
- What was measured
- Bone density, osteomalacia, rickets, falls, colorectal cancer, depression, and overall disease risk
THE PAPER
Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/ml).
Vieth R. Best Pract Res Clin Endocrinol Metab, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.